Breast cancer anti-estrogen resistance protein 3 (BCAR3), also known as NSP2, was initially identified in a study in which genes involved in the anti-estrogen resistance of breast cancer cells were determined; in that study, several genes were collectively named breast cancer anti-estrogen resistance (BCAR) genes [5]. This evidence concerns the gene BCAR3 and breast cancer.